Rivaroxaban Good Manufacturer supply High Quality 366789-02-8
- Molecular Formula:C19H18ClN3O5S
- Molecular Weight:435.888
- Vapor Pressure:0mmHg at 25°C
- Melting Point:228-229°C
- Refractive Index:1.633
- Boiling Point:732.609 °C at 760 mmHg
- PKA:13.36±0.46(Predicted)
- Flash Point:396.868 °C
- PSA：116.42000
- Density:1.46 g/cm3
- LogP:3.04080
Rivaroxaban (366789-02-8) Usage
Rivaroxaban is an orally active, direct inhibitor of Factor Xa (Ki = 0.4 nM), which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade. It demonstrates >10,000-fold greater selectivity for Factor Xa compared to other related serine proteases (thrombin, trypsin, plasmin, FVIIa, FIXa, FXIa, urokinase, and activated protein C). In various animal arterial and venous thrombosis models, rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms.
How to get the best price on Rivaroxaban?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Rivaroxaban . You can buy high quality, low price Rivaroxaban 366789-02-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
